Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review
Goohyeon Hong, Patrick Geraghty · 2023
Read Afatinib-Induced Tumor Lysis Syndrome in Pulmonary Adenocarcinoma: A Case Report and Literature Review by Goohyeon Hong, Patrick Geraghty (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10745128.txt.
Description
Goohyeon Hong and Patrick Geraghty present a case report from twenty twenty-three on a rare crisis sparked by a lung cancer drug. Tumor lysis syndrome hits when cancer cells die fast and flood the blood with their innards. It is a known threat in blood cancers, rare in solid tumors. The patient was a man in his late fifties with lung adenocarcinoma that had spread wide.
He took afatinib, a drug aimed at a growth switch found in his tumor. Four days in, his kidneys failed and his breath worsened. Labs fit tumor lysis from the drug. The team calls it the first such case for this drug in this cancer, with a tour of past reports.
Catalog record
| CREATOR | Goohyeon Hong, Patrick Geraghty |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |